$BGLC

1 thesis

bullish 100%neutral 0%bearish 0%

Avg return (3m)

—

Win rate (3m)

— (0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$BGLCSEC 13Dbullish

Long 338,709 shares of BGLC

338,709 shares · 11.5% of class · 2026-08-13

Tan Lee Su-Leng disclosed a 11.5% stake of 338,709 shares in BioNexus Gene Lab Corp (BGLC) in a Schedule 13D filed 2026-08-14.

End of results.